Corticosteroids, Dopamine Antagonists, and Other Drugs

Optimal Selection of Antiemetics in Children Receiving Cancer Chemotherapy
Methodology of Antiemetic Trials: Response Assessment, Evaluation of New Agents, and Definition of Chemotherapy Emetogenicity
Delayed Emesis Following Anticancer Chemotherapy
Antiemetic Strategies for High-Dose Chemoradiotherapy-Induced Nausea and Vomiting
Consensus Proposal for 5-HT3 Antagonists in the Prevention of Acute Emesis Related to Highly Emetogenic Chemotherapy
Anticipatory Nausea and Vomiting in the Era of 5-HT3 Antiemetics
Consensus Regarding Multiple-Day and Rescue Antiemetic Therapy
Etiology and Prevention of Emesis Induced by Radiotherapy
Statistical Considerations in the Design, Conduct, and Analysis of Antiemetic Clinical Trials
Neuropharmacology of Emesis and Its Relevance to Antiemetic Therapy.